Ihotautilääkäri Kari Saarinen

Kari Saarinen

Melanoma Skin cancer
Dermatopathy Oncology

Specialist in Dermatology

Language proficiency: 

Finnish, Swedish, English

Areas of special expertise: 

Diagnosis and treatment of skin cancer (basal cell carcinoma, squamos cell carcinoma and melanoma)


Skin cancer diagnosis, dermatoscopy, biopsies, follow-up on patients with melanoma, digital mole monitoring (Digital Epiluminescence Microscopy)

Show more


Specialist in Dermatology and Venerology, University of Helsinki 1993
M.D., University of Tampere 1983

Work experience 

  • Docrates Cancer Center, Specialist 2016-
  • Päijät-Häme Central Hospital, Head of Department 2001-
  • Tawam University Hospital, UAE, Consultant Dermatologist 1998-2000
  • Tampere University Hospital, Specialist 1997-1998
  • Kymenlaakso Central Hospital, Head of Department 1994-1997

Memberships and positions of trust 

Finnish Dermatological Society, Member of the Board 2006-2009
Finnish Dermatological Society, Secretary 2003-2006


Kari Saarinen started specialising in dermatology in 1986 in Lahti and the old Unioninkatu clinic in Helsinki. Already in the 1980s, it was seen how skin cancer would proliferate, and Saarinen was actively studying skin surgery right from the specialisation phase.

At Päijät-Häme Central Hospital, Saarinen has been responsible for skin cancer surgery, tumor cryosurgery, photodynamic treatment of skin cancer and monitoring of melanoma patients. Päijät-Häme Central Hospital was the first hospital in Finland to begin digital monitoring of high-risk patients with skin-lesions and melanoma patients already in 1999. Saarinen has developed the system and trained nurses to ensure that a large number of patients are covered by a reliable monitoring system. He has been trained in dermatoscopy, an early detection of skin cancer, through numerous courses and congresses. Saarinen also teaches dermatoscopy both in Finland and abroad.

At Docrates Cancer Center, Saarinen offers expertise in the early diagnosis of skin cancer and in the monitoring of patients with melanoma. The practice has in use a digital skin-lesion imaging system which allows detecting new skin changes and skin-lesions and the microscopic changes in the lesions. Thus, melanoma is often found at a very early stage, when its prognosis is excellent. According to several different studies, patients with melanoma have a two- to ten-fold risk of having one or more melanomas, so active monitoring is important.

Show less